Briaud Financial Planning Inc purchased a new stake in shares of Colgate-Palmolive (NYSE:CL – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 361 shares of the company’s stock, valued at approximately $32,000.
Other large investors have also recently bought and sold shares of the company. D Orazio & Associates Inc. increased its holdings in Colgate-Palmolive by 3.9% during the 3rd quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock valued at $297,000 after purchasing an additional 108 shares in the last quarter. Commonwealth Financial Services LLC increased its holdings in Colgate-Palmolive by 4.5% during the 4th quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company’s stock valued at $247,000 after purchasing an additional 118 shares in the last quarter. Lantz Financial LLC increased its stake in shares of Colgate-Palmolive by 0.6% in the 4th quarter. Lantz Financial LLC now owns 20,140 shares of the company’s stock valued at $1,831,000 after buying an additional 122 shares during the period. Horizon Kinetics Asset Management LLC increased its stake in shares of Colgate-Palmolive by 4.2% in the 3rd quarter. Horizon Kinetics Asset Management LLC now owns 3,102 shares of the company’s stock valued at $322,000 after buying an additional 124 shares during the period. Finally, Pine Haven Investment Counsel Inc increased its stake in shares of Colgate-Palmolive by 1.0% in the 4th quarter. Pine Haven Investment Counsel Inc now owns 13,006 shares of the company’s stock valued at $1,182,000 after buying an additional 130 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
CL has been the subject of several research reports. Raymond James reissued an “outperform” rating and issued a $105.00 target price (down from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Piper Sandler lowered their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. StockNews.com raised Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Monday, March 3rd. Wells Fargo & Company lowered their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research note on Tuesday, January 7th. Finally, Royal Bank of Canada restated a “sector perform” rating and issued a $101.00 price target on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $101.61.
Colgate-Palmolive Trading Up 0.7 %
Shares of NYSE:CL opened at $97.46 on Tuesday. Colgate-Palmolive has a 12-month low of $85.32 and a 12-month high of $109.30. The stock has a market cap of $79.09 billion, a PE ratio of 27.69, a P/E/G ratio of 4.20 and a beta of 0.40. The business has a 50 day moving average of $88.97 and a 200-day moving average of $95.06. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40.
Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the previous year, the firm earned $0.87 earnings per share. As a group, equities research analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current year.
Colgate-Palmolive Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.05%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is presently 56.82%.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- What is a Dividend King?
- How to Protect Your Portfolio When Inflation Is Rising
- Growth Stocks: What They Are, What They Are Not
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- What does consumer price index measure?
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.